Help U-M Biomedical Research Teams Compete in the Annual STAT Madness Tournament

University of Michigan research into COVID-19 complications, cancer and surprise medical bills competes among the nation’s top discoveries of the past year.

9:00 AM

Author | Ian Demsky

teal background saying Stat madness 65 institutions compete for the best innovative research of the year
Credit: Stat Madness

It's like college basketball's March Madness — only for biomedical research. Throughout the month of March, 64 discoveries from schools and colleges across the country will compete in the annual STAT Madness tournament.

This year, the University of Michigan is fielding five research teams whose members hail from Michigan Medicine, the U-M College of Engineering and the School of Public Health.

Not only are bragging rights on the line, but the tournament is a chance to help the public learn about exciting, important scientific advances — many of them funded with federal tax dollars. The event is run by STAT, a health news organization and part of Boston Globe Media.

Michigan fans can cheer U-M teams to victory by casting votes daily on the tournament website. And also by encouraging others to do so on social media.

This year's U-M entries include:

1. New cause of COVID-19 blood clots identified

Blood clots continue to wreak havoc for patients with severe COVID-19 infection. A Michigan Medicine study explains what may spark them in up to half of patients: an autoimmune antibody that's circulating in the blood, attacking the cells and triggering clots in arteries, veins and microscopic vessels.

2. Mapping the immune landscape of pancreatic cancer

A U-M Rogel Cancer Center study used multiple cutting-edge techniques to create what is believed to be the most robust and detailed portrait to date of the network of interactions that suppress the body's immune response in and around pancreatic tumors. The finding could help guide personalized immunotherapy treatment.

MORE FROM THE LAB: Subscribe to our weekly newsletter

3. Nanomedicine targets recurring brain cancer

A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier could deliver cancer-killing drugs directly to malignant brain tumors, research from Michigan Medicine and the U-M College of Engineering scientists showed.

4. COVID-19's long-term effects

For many survivors of severe cases of COVID-19, getting out of the hospital is just the beginning of a long journey to recovery. A team from the U-M Institute for Healthcare Policy and Innovation published some of the first hard data showing this "long COVID" phenomenon, based on patients treated at 28 Michigan hospitals during the first months of the pandemic.

5. Surprise surgery bills

When a patient gets scheduled for an operation, many might know it's important to make sure their surgeon accepts their insurance so they don't end up with a "surprise" bill. But a study from an IHPI team shows that many patients may get stuck with such bills anyway — and the findings may have helped inform federal and state policy changes.

The university is hoping to bring the STAT Madness title back to Michigan this year. A Michigan Medicine research team was crowned the tournament victors in 2019 for a potential tinnitus treatment. A cross-campus team made the finals in the 2017 tournament, and a Michigan Medicine team made the semifinals in 2018.

 

Like Podcasts? Add the Michigan Medicine News Break on iTunes, Google Podcast or anywhere you listen to podcasts.


More Articles About: Lab Report Basic Science and Laboratory Research Covid-19 Health Care Delivery, Policy and Economics Cancer Research All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories green background with white drawing of doctor at patient beside having conversation
Health Lab
Have a seat, doctor: Study suggests eye level connection makes a difference in hospitals
When doctors sit at hospitalized patients’ bedsides, it can have a more positive impact than if they stand, a review of data suggests – but a new study seeks to find out for sure.
blue purple cell dots on white background all over in different patterns
Health Lab
Research finds possible therapies to target oncogenic transcription factors in multiple cancer types
A study from the University of Michigan Health Rogel Cancer Center furthers research that suggests the potential of developing new cancer treatments to target oncogenic transcription factors by indirectly affecting their ability to access enhancer DNA in chromatin.
bottle cap red
Health Lab
Bipolar disorder and alcohol: It’s not as simple as 'self-medication'
People with bipolar disorder have a high risk of alcohol use issues, which have been seen as “self medication,” but a study shows that changes in drinking predict worse symptoms.
iv chemo bags
Health Lab
Drug-chemo combo increases cancer treatment efficacy
A study finds giving a fatty acid inhibitor alongside chemotherapy could improve the treatment efficacy for patients with brain metastases from triple negative breast cancer
white coats hanging and one swinging off hanger with purple haze over them and sunshine peeking through
Health Lab
Who feels ready for residency?
Helen Morgan, M.D., of Michigan Medicine, authored a study that surveyed obstetric and gynecology residents to determine who feels prepared for the transition from medical school to residency.
close up photo of yellow pills lined up on a bright blue matt
Health Lab
New drug candidate blocks resistance to cancer therapies
A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance.